We would love to hear your thoughts about our site and services, please take our survey here.
My take on it - why would he just thank the LTH's ?
Surely he would thank all shareholders, as many could have bought in the low teens a month or two ago and therefore supporting the company, but not necessarily regarded as LTH's.
//cont
There is no visual or familial historical information to indicate whether the baby has the condition so you have to treat all babies the same, and as previously mentioned then the hospital staff also want to try and protect against CMV, so Gentamicin is widely used. You could ask why use Gentamicin if can affect hearing in new born babies ? I also have a friend who is an anaesthetist and he says that it is used because it is effective and very cheap …. and also used globally.
I could provide an example of some numbers from one county in England but not sure if it would be regarded as confidential or an ethical breach, but also in respect to the people affected by this then I feel it’s unfair to provide numbers as an individual statistic. I can say from the numbers of babies born - in that County - and that number divided by 500 actually equates to the approximate 0.2% of babies with PCHI (Permanent Childhood Hearing Impairment), so this in line with the numbers provided by Genedrive and the national statistic - Please note that it is not verified whether every baby affected with PCHI was given Gentamicin; although it is assumed that most babies that were admitted to NICU wards and given it, but not all babies given it have a hearing loss, but 0.2% did and hence the need for testing all babies in NICU where Gentamicin would be considered for use.
From the info above than it's easy to guess and make up possible numbers of how many PoC testers would be sold and how many test assays would be purchased/used by each specific hospital. It was mentioned in a seminar (2020) that a test assay would be about £50, but I think this is now approx. £80 – not a lot if you’re trying to prevent the hearing loss in a child and a lifetime of ongoing support and costs. As a guestimate just for the UK alone then this could be huge with the full approval from NICE, but with FDA approval it could be monumental; as I’m sure it will give a head’s up globally as the AIHL problem is global. Here is an example of how information spreads:- https://onlinelibrary.wiley.com/doi/10.1111/jpc.16302?af=R
Although Genedrive isn’t mentioned in the article, you can assume it’s referring to their PoC test.
It is up to the individual for their own financial decisions and I’m not saying whether to buy, sell or hold Genedrive. Also, I’m not going to throw about figures of multi-million sales or comments of big Pharma takeovers, etc; I’m only providing some information I know to be true and the reason why I’m invested. As a minimum, you should DYOR and stay informed but don’t make rash decisions with some of the information provided on this board.
again, apologies for the long posts
Apologies for long posts
I haven’t posted on LSE for quite some time, and generally it was on another share I’m heavily invested in. I decided to post here, not to just jump on the bandwagon because the share should possibly rocket in the next few weeks; but to share some information and provide some numbers because I know someone who works as a Newborn Hearing Screener. As they work in the NHS then there is confidentiality to consider, so no names will be provided; but also information regarding Genedrive’s PoC and it’s possible general use in NHS Hospitals can be openly sourced or now not subject to any disclosure restriction.
Since at least 2020, the use of the Genedrive PoC tester has been discussed in Hospitals in the UK and there were/are seminars run in Audiology departments; so people who work in those departments and some in Maternity are aware of the benefits of early stage testing for possible AIHL when the antibiotic Gentamicin is administered to babies – their views are very positive. The genetic condition - aminoglycoside susceptibility - can affect 1 in 500 people and is prevalent in all ethnic groups. Obviously, people here could jump the gun and do simple maths and come up with concocted numbers; which could just fool some investors. I would rather try use approximate numbers from what can found on the web, and at least I’ve tried to provide accurate information.
The birth rate in the UK has dropped down the past few years, maybe because of Covid, but still there was 694,685 live births in 2021 (figures for 2022 not fully released). Therefore, using the 1:500 ratio then 1389 babies could have had aminoglycoside susceptibility, which could be affected by Gentamicin. Of course, anyone with a modicum of sense would know that not all newborn babies would not be tested for the gene, because very many are healthy and have no issues. Gentamicin is generally only used when required because there are specific complications and the baby has been admitted to the Neonatal Intensive Care Unit (NICU). The complications could be because of premature birth or other physical diagnosed problems. Again, You cannot just say that every baby would be given Gentamicin just because they are admitted to the NICU ward; but as a general prevention method against possible infection of Cytomegalovirus (CMV) then Gentamicin is given to prevent this. There are no exact figures for this but I was told that most babies, in NICU, are given the antibiotic. CMV can cause hearing loss – you can find more info online regarding this.
To put numbers on the above stats, then in the UK approximately 90,000 babies are admitted to NICU each year – that’s 1 in 7.7 babies; which is actually quite a substantial statistic. So, if you are informed on this board, then you will know the numbers bandied about, are that the PoC test could potentially prevent the hearing loss on 180 babies per year – 90,000 / 500 = 180 – 0.2%
//cont
Dodge - I can safely say I've not been robbed of any of my GGP shares and have full confidence in where GGP is going. It's been a tough 18 months for all invested and maybe some more months to bear whilst the economic climate is bleak; but there is a global economic downturn and many shares have been affected with massive SP drops; and in my opinion there's been too many on here to micro focussed on this investment only and not the overall market. Also too much whining and distraction on the 'shorts'/'NCM games' and losing focus on what Havieron can and will deliver for GGP. If you were confident in what Havieron is - as it's the main anchor for your investment for GGP - then why worry about the shorts.
I'm confident the FS will deliver a strategic plan to move forward to production for the market to see and new investment should start to rolling in; Yes, and it may be a slow climb and maybe take longer than people originally expected, but Havieron will deliver value to Greatland and all those patient genuinely invested PI's.
GLA
The 'Yes' camp have smashed it out the park and provides Shaun and the Board the backing with full confidence to forge ahead with their roadmap for the company.
Unfortunately we are still in downturn of the economy and I don't expect a massive rush of new investment, so maybe some small increases in SP will come in the next few weeks/months until the FS.
It is the same boat for all juniors and also other companies at the present time in struggling to get any new investment; but let's remember many of those companies do not have a Havieron to underpin the investment and when the FS comes and the road to production is paved then I'm sure the SP will eventually start to reflect true value and the genuine and patient investors will be well rewarded.
I'm sure it will be a resounding 'Yes' to all resolutions and the company can move forward with the confidence of shareholder backing (which is never in doubt for the genuine and patient PI's). I'm hoping for an uplift to the SP over the next few weeks ...... and fast forward to when the FS will be delivered and then we should start seeing real SP value return - but patience is still required, as it still a good while off to production and slow and steady increases are better than pump and dump cycles.
Not here to ramp or provide false negative/positive expectations. I was talking to my sister last night (who works in the NHS) and she said there was approx 300000 recorded covid cases in Scotland last week;
https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.bbc.co.uk/news/uk-scotland-60707979&ved=2ahUKEwi3hfqc7Mj2AhWgQUEAHeHeBgIQFnoECAoQAQ&usg=AOvVaw3PgB-m1MFeYi7iTYCIXvC_
That's equivalent to approx 5.5 % of the Scottish population. Transpose that to England and it is approx 3 million cases; which maybe sounds improbable and the figure could be significantly less; but take into account the lack of masks, no real visible public info regarding washing hands and/or using hand gel, etc - and also take into account the complacency that surrounds us all in most of England, then is it possible to have so many cases ? or even more ?
They still have a 'mask in public places' policy in Scotland yet the cases increased, So in reality then any guestimate figures for England are possible ?
Folks - if anyone is upset at the fact that Newcrest have not released an interim report tonight and think Sandeep/Newcrest have thrown the toys out the pram then email SB direct and ask why :- sandeep. biswas @ newcrest .com .au (without any of the spaces)
Otherwise, without factual answers or RNS information then it's all speculation and fictional discussion from posters that only creates FUD on the board.
Looks like Shaun (and the Team) took the bull by the horns and decided to crank up the odds for the 5% and put some pressure on NCM to reconsider their decision to push the MRE back to near the end of the year.
I would think that the decision to get independent verification and release the information was outlined to NCM; therefore showing that Greatland certainly have their own ideas on where they think the 5% figure starts at, so no point NCM coming in with a ridiculous offer.
I haven't posted on the LSE boards for a few months but I do read the boards everyday. My previous posting was generally always in GGP, as it's my largest holding, but my second largest (by value) was EUA. I have my personal reasons for not posting for quite a long time.
I have sold up today at a very considerable loss, and at a point in future then I might buy back in as I believe in the fundamentals here, but I cannot take the risk of letting my money possibly dribble away further. If I buy back in the future and end up with less shares I sold today then it's my risk and one I'm willing to take
My losses today are nothing compared to the loss by the people of Ukraine. Everyone on here makes their own choices but unfortunately the people of Ukraine are having their choices for freedom and life itself being forcefully taken away from them.
I am not here to ramp or deramp this share; all I want to do is remind everyone to keep themselves well informed of what is occurring in Ukraine and how it will affect Russia in the long run. If you think the 'experts' posting on here are correct and this is going to blow over soon then sit back and take the risk; but no one on here should ridiculing others who don't want to take the risk but want to give their honest opinion on what is occurring.
For instance, It has now been stated by Russia that they will be taking out targeted areas and buildings in Kiev; in real terms then that means they will be carrying out heavy and precision bombing to weaken Kiev for the run in of the massive convoy less than 20-30 miles from the City. Putin is not going to back down for the foreseeable future and he and his cronies are digging themselves in - even whilst stating they will have peace talks tomorrow.
For the present time, there is only going to be more death and destruction.
China will only stand by 'it's partner' for so long and if China starts stepping back then Russia with Putin still as head will become totally untouchable; which of course could maybe seriously impact the future of EUA for a considerable time. Irrespective that we know the world needs what EUA have, then at the present time I'm sure those who need it can find it elsewhere, and if exports from Russia are blocked for years then where does EUA stand.
Of course it is up to everyone to make their own investment decisions and I wish everyone luck with whatever decision they make, but please make sure you read the factual information available and do not make investment decisions with what you read on here.
Good luck to all and for peace in Ukraine.
As much as I would like (and I'm sure everyone else would) for the JPM short to get burnt, then most likely they won't as the market will play it right for them.
They're professionals at what they do and generally always come out on top; and of course they have some third party control over certain markets with the help of their banking, broker and market maker cronies.
Even if they did get burnt then they'll have many fingers in any other pies so they always maintain a positive advantage in the finance game - it's what they do.
IMO then the amount they're shorting will have no real impact on the overall long game; so
I'm sitting tight and not worried in the slightest.
Matty, sorry for your loss and please accept my sincere condolences.
Taking the time to in life to care for and love a family member or even a friend shows you have true compassion and faith in life.
At 59 you should still have the confidence to work in life, because with age and wisdom You still have plenty to offer in your lifetime and dedicating the last 6 years of your life caring for someone is true life experience and shows employers you are thoughtful, caring, resourceful, unselfish and dedicated - skills that are appreciated in the workplace, especially in the modern day.
Invest4theLT already posted today's updated list, from Genedrive, earlier in this thread; and it clearly shows Omicron variant is covered in the surveillance programme:- https://www.genedrive.com/assays/cov19-id-variant-surveillance.php
Indomie - why would you post a variant list dated 19th July 2021 - that was published many months before the Omicron variant was discovered ?
JJane - good post and provides a reminder on how much NCM are targeting for growth. IMO then GGP will be pushing back any negotiations on the 5% until the MRE update is released.
Shaun has not put an experienced team together for them to not know the full potential at Havieron at the present time and for future growth; so they certainly won't be agreeing to any low ball offer.
I'm so pleased I'm still holding GGP shares; it's been a tough year but especially a real tough few months. Many have said hold for gold and the same applies today - don't listen to idiots who say they've sold, etc; and don't comment on their threads to give them attention.
I commented Wednesday afternoon:- "I just hope there's enough buying pressure to maintain the SP in the high 14 - 15 range or slightly higher today, so we can then maybe have at least another penny or two added before the Xmas break". hopefully we maybe add a few more pence on to that; but there's no need for way over the top predictions of what the SP will be in a few weeks, steady rises brings the prizes.
Tex - a had a browse a couple of hours ago for some of the crew but none of them about. I think they'll be hoping for a retrace back a few pence and then they'll turn up and say it was in the charts, etc.
I just hope there's enough buying pressure to maintain the SP in the high 14 - 15 range or slightly higher today, so we can then maybe have at least another penny or two added before the Xmas break.
Shaun has put together a very experienced well balanced team who will not be bowled over with a lowball offer. Newcrest know this also and being experts in their field then they have a reasonable idea how big Havieron will be; so they will have to come in with a decent respectable offer.